Get startedLog in
    Picture of Arbutus Biopharma logo

    ABUS — Arbutus Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

    Picture of Arbutus Biopharma logoArbutus Biopharma
    09/11/2023 22:10
    Nov 9 (Reuters) - Barinthus Biotherapeutics PLC
 2ABy.F :
    * BARINTHUS BIO PRESENTS INTERIM DATA FROM PHASE 2B HBV003
TRIAL
AND PHASE 2A AB-729-202 TRIAL IN COLLABORATION WITH ARBUTUS
BIOPHARMA IN CHRONIC HBV PATIENTS AT AASLD
    * BARINTHUS BIOTHERAPEUTICS PLC - VTP-300 WAS GENERALLY
WELL-TOLERATED IN BOTH TRIALS

Source text for Eikon:  ID:nGNX6GRbP8 
Further company coverage:  2ABy.F 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Arbutus Biopharma

    See all news